In a short time, more than 100 patients contacted the site and volunteered for the study, even though they know that it is only a short safety study, not a long-term treatment for them. Jesse Cedarbaum, professor, neurologist, and clinical trialist at Yale School of Medicine, told Tides Global that current treatments mostly focus on symptoms
Rotate them across sessions instead
The mechanism of hemolysis in PK deficiency is not clear
Mean body weight change at 80 weeks: 12.7% on 4 mg 19.1% on 9 mg 20.8% on 12 mg versus 4.0% with placebo
"If you have a person who truly is a diabetic and needs this medication, that's a problem that they can't get their hands on a medicine they need
ADDITIONAL RESEARCH & SCIENTIFIC DATA